Sana Biotechnology
Seattle · Founded 2018
About Sana Biotechnology
Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients. Recent scientific advances make it possible to reprogram cells in the body or replace damaged cells and tissues, creating a new class of medicines to treat a broad array of diseases. The company is a team of scientists, clinicians and biotechnology veterans focused on creating an enduring company that makes meaningful medicines and will change the approach in treating diseases.
Company Facts
- Founded: 2018
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Total funding: $951.3M
- Funding stage: IPO
- Last round: Post-IPO Equity (Aug 2025)
- Ticker: nasdaq:SANA
- Website: sana.com
- Phone: +1 206-701-7914
Industries & Categories
Biotechnology, Health Care, Life Science, Product Research
Social Profiles
Canonical: https://fsome.com/organization/sana-biotechnology-44523 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.